디지털 치료기기의 특성 및 사용 평가: reSET®, reSET-O®, Somryst®를 중심으로 한 탐색적 연구Characteristics and User Evaluation of Digital Therapeutics: An Exploratory Study Focusing on reSET®, reSET-O®, and Somryst®
- Other Titles
- Characteristics and User Evaluation of Digital Therapeutics: An Exploratory Study Focusing on reSET®, reSET-O®, and Somryst®
- Authors
- 정유림; 박은영; 백동재; 방준석; 김광준
- Issue Date
- Oct-2023
- Publisher
- 대한약학회
- Keywords
- Characteristics of digital therapeutics; User evaluations; Pharmacist
- Citation
- 약 학 회 지, v.67, no.5, pp 285 - 293
- Pages
- 9
- Journal Title
- 약 학 회 지
- Volume
- 67
- Number
- 5
- Start Page
- 285
- End Page
- 293
- URI
- https://scholarworks.sookmyung.ac.kr/handle/2020.sw.sookmyung/159810
- DOI
- 10.17480/psk.2023.67.5.285
- ISSN
- 0377-9556
2383-9457
- Abstract
- Digital therapeutics (DTx) are defined as high-quality software designed to prevent, manage, and treat medicaldisorders or diseases by providing evidence-based therapeutic interventions. In this study, an investigation was conducted to examine the characteristics of DTx, including their methods, safety-related data, and user evaluations of reSET®, reSET-O®, and Somryst®. These DTx solutions have recently obtained the first FDA approval and the first insurance code registration by government. However, there are limitations in terms of the quantitative scale of patient feedback evaluations and concerns about accuracy, as indicated by research findings. Nevertheless, with the active global development of DTx and the increasing scale of investment, pharmacists need to pay attention to and prepare for this innovative treatment concept.
- Files in This Item
-
Go to Link
- Appears in
Collections - 약학대학 > 약학부 > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.